The FRONTIER Stent Registry
Safety and Feasibility of a Novel Dedicated Stent for the Treatment of Bifurcation Coronary Artery Lesions
Thierry Lefèvre, MD*,*,
John Ormiston, MD
,
Giulio Guagliumi, MD
,
Heinz-Peter Schultheiss, MD
,
Laurent Quilliet, MD||,
Bernhard Reimers, MD¶,
Philippe Brunel, MD#,
Williams Wijns, MD**,
H.J. Buettner, MD
,
F. Hartmann, MD
,
Susan Veldhof, RN
,
Karin Miquel, PhD
,
Xiaolu Su, MS
and
Willem J. van der Giessen, MD||||
* Institut Jacques Cartier, Massy, France
Green Lane/Mercy Hospital, Auckland, New Zealand
Ospedali Riuniti, Bergamo, Italy
Hospital Benjamin Franklin, Berlin, Germany
|| Hopital Trousseau, Tours, France
¶ Ospedale Civile, Mirano, Italy
# Clinique St Henri, Nantes, France
** OLVG Aalst, Aalst, Belgium

Herz-Zentrum, Bad Krozingen, Germany

Universitatsklinikum Lubeck, Lubeck, Germany

Guidant Europe, Diegem, Belgium
|||| Erasmus Medical Centre, Rotterdam, the Netherlands

View larger version (81K):
[in a new window]
|
Figure 1 (A to E) Deployment sequence of the Frontier stent. (A) The system is advanced into the main branch over a conventional rapid-exchange wire. (B) The joining mandrel is retracted to release the over-the-wire side branch tip. A long guidewire is inserted into the side branch. (C) The system is advanced up to the carina. (D) With a single inflation device, the stent is deployed by kissing balloon inflation. (E) After deflation the delivery system is retracted.
|
|

View larger version (17K):
[in a new window]
|
Figure 2 Bifurcation lesion classification from the Duke University Angiographic Core Lab, Duke University, Durham, North Carolina. Type A: Prebranch stenosis not involving the ostium of the side branch. Type B: Postbranch stenosis of the parent vessel not involving the origin of the side branch. Type C: Stenosis encompassing the side branch but not involving the ostium. Type D: Stenosis involving the parent vessel and ostium of the side branch. Type E: Stenosis involving the ostium of the side branch. Type F: Stenosis directly involving the parent vessel and ostium of the side branch.
|
|

View larger version (18K):
[in a new window]
|
Figure 3 Kaplan-Meier curves: survival to 180 days, survival free of major adverse cardiac events (MACE), myocardial infarction (MI), and target lesion revascularization (TLR) (intent-to-treat population).
|
|
Copyright © 2005 by the American College of Cardiology Foundation.